54 filings
8-K
ASRT
Assertio Holdings Inc
2 Apr 24
Departure of Directors or Certain Officers
5:05pm
8-K
ASRT
Assertio Holdings Inc
27 Mar 24
Other Events
7:40am
8-K/A
ASRT
Assertio Holdings Inc
12 Mar 24
Results of Operations and Financial Condition
5:01pm
8-K
ASRT
Assertio Holdings Inc
11 Mar 24
Assertio Reports Fourth Quarter and Full Year 2023 Financial Results
5:07pm
8-K
ASRT
Assertio Holdings Inc
23 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
8-K
dvm 5h1lf
26 Jan 24
Departure of Directors or Certain Officers
5:00pm
8-K
rzgapi rec
5 Jan 24
Departure of Directors or Certain Officers
5:00pm
8-K
jzd27qh66izug
14 Nov 23
Departure of Directors or Certain Officers
12:00am
8-K
elaw83sce1y
8 Nov 23
Assertio Reports Third Quarter 2023 Financial Results
4:03pm
8-K/A
wv480
10 Oct 23
Completion of Acquisition or Disposition of Assets
4:00pm
8-K
aqvnbu2bohe zele5fo3
3 Aug 23
Assertio Reports Second Quarter 2023 Financial Results, Closes Spectrum Acquisition
4:08pm
8-K
kdh5y5o1kezr iz5
31 Jul 23
Assertio Holdings, Inc Announces Favorable Vote on Proposed Acquisition of Spectrum Pharmaceuticals
8:14pm
8-K
tls3pc4ieden43cod
14 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:00pm
8-K
7bo2zgwx8i0knhv
15 May 23
Departure of Directors or Certain Officers
4:00pm
8-K
5ox09umn7p3kjsilgr5s
9 May 23
Assertio Reports First Quarter 2023 Financial Results, Raises Full Year 2023 Outlook
7:15am
8-K
mbljd9h6cavzhux6wzgh
25 Apr 23
Regulation FD Disclosure
4:37pm
8-K
1igo6xuswmb eip60p
25 Apr 23
Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in All Stock and CVR Transaction
9:26am
8-K
7596qb6 70i
10 Mar 23
Regulation FD Disclosure
6:04pm
8-K
ij5ezaa
8 Mar 23
Assertio Reports Fourth Quarter and Full Year 2022 Financial Results
4:02pm
8-K
2zw9hfeu
23 Feb 23
Assertio Announces Exchange Offer of $30 Million of its Currently Outstanding 6.50% Convertible Senior Notes Due 2027
7:05am